Examkin

Soru

Zorluk: ZorDiagnostic Workup and Test Sequencing

A 28-year-old woman presents to the outpatient clinic to discuss laboratory results obtained during a health screening for a new life insurance policy. She feels well and reports no bone pain, abdominal pain, nausea, polyuria, polydipsia, or mood changes. The patient has no personal history of fractures, peptic ulcer disease, or nephrolithiasis. Family history is notable for her father having a chronically elevated calcium level that "never required treatment or surgery." Vital signs are within normal limits. Physical examination reveals a non-tender neck with no palpable masses or thyromegaly.

Initial laboratory evaluation shows:
Serum calcium: 11.3 mg/dL11.3\text{ mg/dL} (normal: 8.4−10.2 mg/dL8.4-10.2\text{ mg/dL})
Serum albumin: 4.0 g/dL4.0\text{ g/dL}
Serum phosphorus: 2.4 mg/dL2.4\text{ mg/dL} (normal: 2.5−4.5 mg/dL2.5-4.5\text{ mg/dL})
Intact parathyroid hormone: 82 pg/mL82\text{ pg/mL} (normal: 10−65 pg/mL10-65\text{ pg/mL})
25-hydroxyvitamin D: 34 ng/mL34\text{ ng/mL} (normal: 20−50 ng/mL20-50\text{ ng/mL})
Serum creatinine: 0.8 mg/dL0.8\text{ mg/dL}

Which of the following is the most appropriate next step in the diagnostic workup for this patient?

  1. 24-hour urine calcium and creatinine excretionCevap
  2. B
    Technetium-99m sestamibi parathyroid scintigraphy
  3. C
    Dual-energy x-ray absorptiometry of the spine and hip
  4. D
    Neck ultrasonography
  5. E
    Serum parathyroid hormone-related peptide level

Cevap

24-hour urine calcium and creatinine excretion
The correct diagnostic sequence for a patient with newly identified PTH-dependent hypercalcemia (elevated calcium with elevated or inappropriately normal PTH) involves definitively establishing the biochemical etiology before pursuing imaging. The primary differential lies between primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH). FHH is a benign, autosomal dominant disorder caused by a mutation in the calcium-sensing receptor (CaSR). A 24-hour urine collection to calculate the calcium-to-creatinine clearance ratio is essential; a ratio <0.01< 0.01 strongly suggests FHH, while a ratio >0.02> 0.02 points toward PHPT. Establishing this diagnosis early is critical because patients with FHH require no treatment and will not benefit from parathyroidectomy.

Adım Adım Çözüm

1
Analyze the initial laboratory data.
The patient has hypercalcemia with an inappropriately elevated intact PTH and normal vitamin D, indicating PTH-dependent hypercalcemia.
Establishing whether hypercalcemia is PTH-dependent or PTH-independent guides the next phase of the diagnostic algorithm.
2
Formulate a differential diagnosis based on the biochemical profile.
The two primary etiologies for PTH-dependent hypercalcemia are primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH).
The patient's family history of untreated hypercalcemia specifically raises the clinical suspicion for FHH.
3
Select the appropriate diagnostic test to differentiate the conditions.
A 24-hour urine collection to calculate the calcium-to-creatinine clearance ratio is required.
A clearance ratio of <0.01< 0.01 indicates FHH (which requires no treatment), while a ratio >0.02> 0.02 confirms PHPT, preventing unnecessary surgical intervention in patients with FHH.

Anahtar Kavram

In patients presenting with PTH-dependent hypercalcemia, the diagnosis of primary hyperparathyroidism must be distinguished from familial hypocalciuric hypercalcemia (FHH) using a 24-hour urine calcium and creatinine excretion test before any imaging or surgical planning occurs.
Bu soruyu puanla

Konular

Diagnostic Workup and Test Sequencing

Bu konudan daha fazla soru